RIYADH: The 9th Saudi Pediatric Neurology Society conference and workshops will be held from Nov. 20-23 at the Crowne Plaza RDC in Riyadh.
The SPNS, established in 2012, is an official non-profit scientific association under the auspices of the Saudi Commission for Health Specialties.
This year’s conference promises insights into various topics, including neonatal neurology, spinal muscular atrophy, neuro inflammatory disorders, neuromuscular diseases, brain and spinal injuries and infections, epilepsy, brain and spinal tumors, cerebrovascular disease, autism, movement disorders, and metabolic and genetic disorders.
Top healthcare officials, dignitaries, industry leaders, analysts and other experts will participate.
Fahad Al-Bashiri, president of SPNS and a professor and consultant pediatric neurologist at the College of Medicine, King Saud University, will share pivotal insights on the opening day of the event with two presentations addressing some of the most pressing challenges in the field.
The first presentation will cover findings from a recent clinical trial examining the role of vitamin D in managing epilepsy. This research explores how vitamin D supplementation may influence seizure frequency and severity, potentially offering a new approach to epilepsy care.
The second presentation will focus on the newly developed Gulf Cooperation Council guidelines for managing Neurofibromatosis Type 1. This talk will discuss the standardized approach proposed for the region, aiming to optimize patient care and outcomes for individuals with NF1.
Dr. Ahmad Alanazi, chairman of the conference and an assistant professor, pediatric neurologist and epileptologist at the College of Medicine, KSU, said: “I am honoured to lead a forum where leading experts will address the latest challenges and breakthroughs in pediatric neurology.
“This year’s conference will spotlight transformative advancements, including the role of artificial intelligence and machine learning in diagnosing and managing epilepsy and neurorehabilitation, signaling a new era in precision care.”
He added: “The SPNS conference remains a premier platform for advancing pediatric neurology, fostering collaboration, and setting new standards of care for young patients in the Kingdom and beyond.”
